Ranbaxy vs. Warner Lambert EP 281: Invalid patent

The Hague District Court, 13 September 2006, in the case of Ranbaxy Uk.Ltd /Ranbaxy Laboratories Ltd versus Warner-Lambert Company.

Contrary to the TBA (EPO), the district court rules that, for the Netherlands, “claims 1 to 3 of the patent should be considered invalid, because the invention incorporated in them is not new, at least these claims lack inventive step. The claim in the principal action will therefore be allowed on the understanding that the court will invalidate claims 1 to 3 of (Warner-Lambert’s) EP 281.”

Read the entire judgment here.

IEFenglish